Lamivudine and Zidovudine (Exelan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Lamivudine and Zidovudine drug offered from Exelan Pharmaceuticals Inc.. This Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Exelan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Lamivudine and Zidovudine |
| SUBSTANCE NAME: | LAMIVUDINE; ZIDOVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-04-29 |
| END MARKETING DATE: | 0000-00-00 |
Lamivudine and Zidovudine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lamivudine and Zidovudine from Exelan Pharmaceuticals Inc. |
| LABELER NAME: | Exelan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150; 300(mg/1; mg/1) |
| START MARKETING DATE: | 2015-04-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76282-115_92484eb6-4da8-47b3-b103-e90ec010cb2a |
| PRODUCT NDC: | 76282-115 |
| APPLICATION NUMBER: | ANDA203259 |
Other LAMIVUDINE; ZIDOVUDINE Pharmaceutical Manufacturers / Labelers:
